Oxymetazoline/Pilocarpine

羟甲唑啉/毛果芸香碱

Report date: 2022/07/04 19:38:02

Base Information

Drug NameOxymetazoline/Pilocarpine
Drug Alias Name毛果芸香碱+羟甲唑啉AGN-199201 + AGN-190584盐酸羟甲唑啉/盐酸毛果芸香碱Oxymetazoline+Pilocarpine羟甲唑啉+毛果芸香碱 +[12] 
ClassificationSmall molecules
Mechanisms of ActionAlpha-1a adrenergic receptor agonistsMuscarinic acetylcholine receptor agonists
TargetsMuscarinic acetylcholine receptorAlpha-1a adrenergic receptor
Therapy Area/IndicationsPresbyopia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Pilocarpine HydrochlorideOxymetazoline Hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsPresbyopia

Other Information

ATC CodeN/A
Related LinksN/A